Data / Drug companies / MSN Laboratories Private Limited
MSN Laboratories Private Limited: 102 products in the FDA NDC directory, labeler code 14501
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
MSN Laboratories Private Limited (labeler code 14501) lists 102 products in the FDA National Drug Code Directory. By type: 102 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on March 28, 2025.
The request: Watch MSN Laboratories Private Limited (FDA labeler code 14501): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 14501
- Products in commercial distribution
- 102
- Packages
- 103
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- March 22, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 102 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 102 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 100 | 98% |
| Liquid | 2 | 2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Diazoxide choline | 14501-0117 | Powder | Bulk ingredients | March 28, 2025 |
| Selexipag | 14501-0116 | Powder | Bulk ingredients | March 28, 2024 |
| Pitolisant | 14501-0114 | Powder | Bulk ingredients | March 27, 2023 |
| Upadacitinib | 14501-0111 | Powder | Bulk ingredients | March 26, 2023 |
| Migalastat hydrochloride | 14501-0115 | Powder | Bulk ingredients | March 25, 2023 |
| Nicardipine hydrochloride | 14501-0113 | Powder | Bulk ingredients | December 30, 2022 |
| Dabigatran etexilate oxalate | 14501-0112 | Powder | Bulk ingredients | August 18, 2022 |
| Ertugliflozin | 14501-0110 | Powder | Bulk ingredients | March 30, 2022 |
| Baloxavir marboxil | 14501-0109 | Powder | Bulk ingredients | March 18, 2022 |
| Mirabegron (alpha-form) | 14501-0108 | Powder | Bulk ingredients | January 31, 2022 |
| Ertugliflozin | 14501-0107 | Powder | Bulk ingredients | August 31, 2021 |
| Baricitinib | 14501-0104 | Powder | Bulk ingredients | November 30, 2020 |
| Isosulfan blue | 14501-0103 | Powder | Bulk ingredients | July 30, 2020 |
| Tafamidis | 14501-0102 | Powder | Bulk ingredients | March 30, 2020 |
| Tafamidis meglumine | 14501-0101 | Powder | Bulk ingredients | March 30, 2020 |
| Rolapitant hydrochloride | 14501-0099 | Powder | Bulk ingredients | March 28, 2020 |
| Edaravone | 14501-0100 | Powder | Bulk ingredients | March 10, 2020 |
| Lofexidine hydrochloride | 14501-0098 | Powder | Bulk ingredients | February 27, 2020 |
| Glycerol phenylbutyrate | 14501-0097 | Liquid | Bulk ingredients | February 27, 2020 |
| Diazoxide | 14501-0096 | Powder | Bulk ingredients | February 19, 2020 |
| Vilanterol trifenatate | 14501-0095 | Powder | Bulk ingredients | October 4, 2019 |
| Bumetanide | 14501-0036 | Powder | Bulk ingredients | June 27, 2019 |
| Cariprazine hydrochloride | 14501-0035 | Powder | Bulk ingredients | December 13, 2018 |
| Clidinium bromide | 14501-0034 | Powder | Bulk ingredients | March 29, 2018 |
| Netupitant | 14501-0033 | Powder | Bulk ingredients | March 31, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.